281 related articles for article (PubMed ID: 23442578)
1. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Ji MK; Shi Y; Xu JW; Lin X; Lin JY
Anticancer Drugs; 2013 Jun; 24(5):461-72. PubMed ID: 23442578
[TBL] [Abstract][Full Text] [Related]
2. Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo.
Xie Q; Tang N; Wan R; Qi Y; Lin X; Lin J
Toxicon; 2011 Apr; 57(5):704-11. PubMed ID: 21329716
[TBL] [Abstract][Full Text] [Related]
3. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.
Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS
Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884
[TBL] [Abstract][Full Text] [Related]
4. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D
BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Boerhaavia diffusa on experimental metastasis by B16F10 melanoma in C57BL/6 mice.
Leyon PV; Lini CC; Kuttan G
Life Sci; 2005 Feb; 76(12):1339-49. PubMed ID: 15670614
[TBL] [Abstract][Full Text] [Related]
6. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis.
Qu XJ; Yuan YX; Tian ZG; Xu WF; Chen MH; Cui SX; Guo Q; Gai R; Makuuchi M; Nakata M; Tang W
Int J Mol Med; 2006 Oct; 18(4):609-14. PubMed ID: 16964412
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
8. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Naglich JG; Jure-Kunkel M; Gupta E; Fargnoli J; Henderson AJ; Lewin AC; Talbott R; Baxter A; Bird J; Savopoulos R; Wills R; Kramer RA; Trail PA
Cancer Res; 2001 Dec; 61(23):8480-5. PubMed ID: 11731431
[TBL] [Abstract][Full Text] [Related]
10. A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Shinoda K; Shibuya M; Hibino S; Ono Y; Matsuda K; Takemura A; Zou D; Kokubo Y; Takechi A; Kudoh S
Int J Oncol; 2003 Feb; 22(2):281-8. PubMed ID: 12527923
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
12. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
[TBL] [Abstract][Full Text] [Related]
13. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
Lu Z; Lu N; Li C; Li F; Zhao K; Lin B; Guo Q
Toxicol Lett; 2012 Mar; 209(3):211-20. PubMed ID: 22245252
[TBL] [Abstract][Full Text] [Related]
14. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
Siveen KS; Kuttan G
Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
[TBL] [Abstract][Full Text] [Related]
15. High-level expression, purification, characterization and structural prediction of a snake venom metalloproteinase inhibitor in Pichia pastoris.
Shi Y; Ji MK; Xu JW; Lin X; Lin JY
Protein J; 2012 Mar; 31(3):212-21. PubMed ID: 22307654
[TBL] [Abstract][Full Text] [Related]
16. A novel taspine derivative, HMQ1611, suppresses adhesion, migration and invasion of ZR-75-30 human breast cancer cells.
Zhan Y; Wang N; Liu C; Chen Y; Zheng L; He L
Breast Cancer; 2014 May; 21(3):334-40. PubMed ID: 22875642
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
Sun CY; Hu Y; Guo T; Wang HF; Zhang XP; He WJ; Tan H
Acta Pharmacol Sin; 2006 Nov; 27(11):1447-52. PubMed ID: 17049120
[TBL] [Abstract][Full Text] [Related]
18. Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Muraishi Y; Mitani N; Fuse H; Saiki I
Anticancer Res; 2001; 21(6A):3845-52. PubMed ID: 11911256
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Li C; Zhao Y; Yang D; Yu Y; Guo H; Zhao Z; Zhang B; Yin X
Biochem Cell Biol; 2015 Feb; 93(1):16-27. PubMed ID: 25453494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
